UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1

Cancer research (Chicago, Ill.), 2004-10, Vol.64 (20), p.7355-7360

2004

Volltextzugriff (PDF)

Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells

Journal of cellular biochemistry, 2004-04, Vol.91 (5), p.973-986

2004

Volltextzugriff (PDF)

Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor β Signaling by Binding to Smad7 and Promoting Its Degradation

Molecular and Cellular Biology, 2004-03, Vol.24 (6), p.2251-2262

2004

Volltextzugriff (PDF)

Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells

Oncogene, 2004-10, Vol.23 (46), p.7651-7659

2004

Volltextzugriff (PDF)

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines

Cancer research (Chicago, Ill.), 2002-09, Vol.62 (18), p.5365-5369

2002

Volltextzugriff (PDF)

Synthesis and cytotoxic activity of 1-(1-benzoylindoline-5-sulfonyl)-4-phenylimidazolidinones

Archives of Pharmacal Research, 2004, 27(5), , pp.478-484

2004

Volltextzugriff (PDF)

Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway

Cancer research (Chicago, Ill.), 2002-07, Vol.62 (13), p.3649-3653

2002

Volltextzugriff (PDF)

Antitumor activity of 4-phenyl-1-arylsulfonylimidazolidinone, DW2143

Cancer letters, 1999-06, Vol.140 (1), p.177-187

1999

Volltextzugriff (PDF)

Decreased Expression of Bone Morphogenetic Protein (BMP) Receptor Type II Correlates with Insensitivity to BMP-6 in Human Renal Cell Carcinoma Cells

Clinical cancer research, 2003-12, Vol.9 (16), p.6046-6051

2003

Volltextzugriff (PDF)

Induction of G2/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells

Biochemical pharmacology, 2001-12, Vol.62 (11), p.1439-1447

2001

Volltextzugriff (PDF)

Inhibition of fos–jun–DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells

Cancer letters, 1998-05, Vol.127 (1), p.23-28

1998

Volltextzugriff (PDF)

Induction of apoptosis by momordin I in promyelocytic leukemia (HL-60) cells

Anticancer research, 2002-05, Vol.22 (3), p.1885

2002

Volltextzugriff (PDF)

Construction of retroviral vectors with enhanced efficiency of transgene expression

Journal of virological methods, 2004-11, Vol.121 (2), p.127-136

2004

Volltextzugriff (PDF)

Characterization of the anticancer activity of DW2282, a new anticancer agent

Anticancer research, 1999-11, Vol.19 (6B), p.5087

1999

Volltextzugriff (PDF)

Pharmacokinetic study of a new quinolone, DW-116

Drugs (New York, N.Y.), 1995, Vol.49 Suppl 2 (Supplement 2), p.323-325

Lee, D K

1995

Volltextzugriff (PDF)

Momordin I, a compound of ampelopsis radix, inhibits AP-1 activation induced by phorbol ester

Cancer letters, 2000-04, Vol.152 (1), p.1-8

2000

Volltextzugriff (PDF)

Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones

Bioorganic & medicinal chemistry letters, 1998-06, Vol.8 (12), p.1547-1550

1998

Volltextzugriff (PDF)

Determination of binding constant of transcription factor AP-1 and DNA. Application of inhibitors

European journal of biochemistry, 2001-02, Vol.268 (3), p.565-572

2001

Volltextzugriff (PDF)

In-vitro and in-vivo activities of DW-116, a new fluoroquinolone

Journal of antimicrobial chemotherapy, 1997-04, Vol.39 (4), p.509-514

1997

Volltextzugriff (PDF)

The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis

Genes & development, 2001-02, Vol.15 (4), p.455-466

2001

Volltextzugriff (PDF)

The Human Papilloma Virus E7 Oncoprotein Inhibits Transforming Growth Factor-β Signaling by Blocking Binding of the Smad Complex to Its Target Sequence

The Journal of biological chemistry, 2002-10, Vol.277 (41), p.38557-38564

2002

Volltextzugriff (PDF)

Human T-cell Lymphotropic Virus Type 1 Tax Inhibits Transforming Growth Factor-β Signaling by Blocking the Association of Smad Proteins with Smad-binding Element

The Journal of biological chemistry, 2002-09, Vol.277 (37), p.33766-33775

2002

Volltextzugriff (PDF)

Determination of binding constant of transcription factor AP‐1 and DNA

European journal of biochemistry, 2001-02, Vol.268 (3), p.565-572

2001

Volltextzugriff (PDF)

Cytotoxic constituents from the roots ofAnthriscus sylvestris

Archives of pharmacal research, 1999-04, Vol.22 (2), p.208-212

1999

Volltextzugriff (PDF)

Continuous Transforming Growth Factor β1 Secretion by Cell-Mediated Gene Therapy Maintains Chondrocyte Redifferentiation

Tissue engineering, 2005-01, Vol.11 (1-2), p.31-318

2005

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(56)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1

Inhibition of AP-1 transcription activator induces myc-dependent apoptosis in HL60 cells

Jab1/CSN5, a Component of the COP9 Signalosome, Regulates Transforming Growth Factor β Signaling by Binding to Smad7 and Promoting Its Degradation

Loss of expression of bone morphogenetic protein receptor type II in human prostate cancer cells

Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen-independent human prostate cancer cell lines

Synthesis and cytotoxic activity of 1-(1-benzoylindoline-5-sulfonyl)-4-phenylimidazolidinones

Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway

Antitumor activity of 4-phenyl-1-arylsulfonylimidazolidinone, DW2143

Decreased Expression of Bone Morphogenetic Protein (BMP) Receptor Type II Correlates with Insensitivity to BMP-6 in Human Renal Cell Carcinoma Cells

Induction of G2/M phase arrest and apoptosis by a new synthetic anti-cancer agent, DW2282, in promyelocytic leukemia (HL-60) cells

Inhibition of fos–jun–DNA complex formation by dihydroguaiaretic acid and in vitro cytotoxic effects on cancer cells

Induction of apoptosis by momordin I in promyelocytic leukemia (HL-60) cells

Construction of retroviral vectors with enhanced efficiency of transgene expression

Characterization of the anticancer activity of DW2282, a new anticancer agent

Pharmacokinetic study of a new quinolone, DW-116

Momordin I, a compound of ampelopsis radix, inhibits AP-1 activation induced by phorbol ester

Synthesis and antitumor activity of 4-phenyl-1-arylsulfonyl imidazolidinones

Determination of binding constant of transcription factor AP-1 and DNA. Application of inhibitors

In-vitro and in-vivo activities of DW-116, a new fluoroquinolone

The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis

The Human Papilloma Virus E7 Oncoprotein Inhibits Transforming Growth Factor-β Signaling by Blocking Binding of the Smad Complex to Its Target Sequence

Human T-cell Lymphotropic Virus Type 1 Tax Inhibits Transforming Growth Factor-β Signaling by Blocking the Association of Smad Proteins with Smad-binding Element

Determination of binding constant of transcription factor AP‐1 and DNA

Cytotoxic constituents from the roots ofAnthriscus sylvestris

Continuous Transforming Growth Factor β1 Secretion by Cell-Mediated Gene Therapy Maintains Chondrocyte Redifferentiation

Suchergebnisse filtern